NCT06455839

Brief Summary

This project is a single-site, single-arm, clinical feasibility trial examining the impact of a single-session, 2-hour connected consciousness breathing with breath retention (CCBR) training for chronic musculoskeletal pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable pain

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 29, 2024

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

June 7, 2024

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 11, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 12, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 27, 2024

Completed
Last Updated

March 21, 2025

Status Verified

March 1, 2025

Enrollment Period

13 days

First QC Date

June 7, 2024

Last Update Submit

March 19, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Number of Participants with Chronic Pain Recruited

    Examine recruitment rates during the 1 week of recruitment.

    1 week

  • Intervention Adherence

    Examine the percentage of participants completing their 2-hour intervention session.

    2 Hours

  • Treatment Acceptability

    Treatment acceptability will be assessed with a 12-item adaptation of the Treatment Framework of Acceptability questionnaire. Scores range from 5 to 45. Higher scores reflect greater acceptability.

    Completed immediately after the 2-hour GRMT training

Secondary Outcomes (1)

  • Global Impression of Change

    Completed at 2- and 6-week follow-ups

Other Outcomes (12)

  • Acute Pain Unpleasantness

    Will be completed immediately before and after the 2-hour intervention session

  • Acute Pain Intensity

    Will be completed immediately before and after the 2-hour intervention session

  • Daily Pain Intensity

    Daily for 6 weeks

  • +9 more other outcomes

Study Arms (1)

Guided Respiration Mindfulness Therapy

EXPERIMENTAL
Behavioral: Guided Resipiration Mindfulness Therapy (GRMT)

Interventions

GRMT provides training in respiratory regulation, mindfulness and relaxation. The GRMT training will begin with a 15-minute introduction to the treatment model, followed by an hour of therapist-guided respiration (i.e., continuous rhythmic expansion of the chest, and relaxed exhalation involving release of all respiratory and peripheral musculature). The final 45 minutes will be used to discuss participant experiences during the GRMT training. GRMT training sessions will occur in-person and in a small group format (\<5 participants each).

Guided Respiration Mindfulness Therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • having received a professional diagnosis of clinical levels of chronic pain
  • being able to not commit to another (new) treatment during the course of the study
  • understanding English instructions fluently
  • Being 18 and above

You may not qualify if:

  • having learned to practice breathwork any time in the past
  • being unable to perform most basic tasks due to pain or pain treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brian Science and Symptom Management Center

Tallahassee, Florida, 32310, United States

Location

MeSH Terms

Conditions

PainChronic PainMusculoskeletal Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 7, 2024

First Posted

June 12, 2024

Study Start

May 29, 2024

Primary Completion

June 11, 2024

Study Completion

July 27, 2024

Last Updated

March 21, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations